Is Jyothy Labs overvalued or undervalued?

As of 4 November 2025, the valuation grade for Jyothy Labs has moved from very attractive to attractive. The company is currently assessed as fairly valued. Key ratios include a PE ratio of 31.12, an EV to EBITDA of 22.19, and a ROCE of 29.33%. In comparison to its peers, Jyothy Labs has a significantly lower PE ratio than Hindustan Unilever, which stands at 54.31, and Nestle India at 81.46, both categorized as very expensive.
Despite the recent stock performance showing a decline of 20.34% year-to-date compared to a 6.81% increase in the Sensex, Jyothy Labs maintains strong profitability metrics, indicating resilience in its operational efficiency. Overall, the valuation suggests that while the stock is not undervalued, it remains a solid investment relative to its more expensive peers in the FMCG sector.